Zhonghuan Zhongjie Biotechnology Participate in Medical and Health Care Industrial investment cooperation promotion conference and successful signing

On February 29, 2024, the 2024 China Binzhou (Shenzhen) Medical and Health Industry Investment and Cooperation Promotion Conference on "Shenzhen Xinglian Rong Binbin Diverse Future" was held in Shenzhen.

Fan Daiming, an academician of the CAE Member, a foreign academician of the American Academy of Medical Sciences, and the former vice president of the Chinese Academy of Engineering, Li Liejun, a foreign academician of the Russian Academy of Engineering, a professor of South China University of Technology, and president of Guangdong Doctor Innovation and Development Promotion Association, Mei Yonghong, a director of Shenzhen Huada Group, chairman of Huada Agricultural Group, and president of Shenzhen Huagu Zhiyuan Biotechnology and Industry Research Institute, Bi Siliang, director of the office of the People's Government of Shandong Province in Guangzhou, Wang Lixin, president of Shenzhen Shandong Chamber of Commerce, Xu Jinkui, rotating president of Shenzhen Financial Chamber of Commerce, Zhang Fengchuan, the book of Shenzhen Pharmaceutical Industry Association, chairman of Ruilide Biotechnology Co., Ltd., Wang Mingxing, executive vice president of Shenzhen Research Institute of Shandong University, and Dashi Pharmaceutical Wang Chunhe, Founder and Chairman, Assistant Director of Shenzhen Bay Laboratory Translational Medicine Center Vice Director Liu Wei and other guests attended the event.

Representatives of pharmaceutical and health enterprises in the Greater Bay Area, representatives of universities, research and development, and financial institutions, representatives of industry associations and chambers of commerce, and representatives of coastal talents in the Greater Bay Area; Representatives of leading pharmaceutical and health enterprises in Binzhou City, as well as key officials from various counties, districts, municipal departments, parks, municipal state-owned enterprises, relevant universities, and medical institutions, participated in the event.

Shandong Zhonghuan Zhongjie Biotechnology Co., Ltd. was invited to participate and signed a contract on site as a key project for the pharmaceutical and health industry in the Greater Bay Area in Binzhou City.